These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17159106)

  • 1. Spectrum and prognosis of neurologic complications after hematopoietic transplantation.
    Denier C; Bourhis JH; Lacroix C; Koscielny S; Bosq J; Sigal R; Said G; Adams D
    Neurology; 2006 Dec; 67(11):1990-7. PubMed ID: 17159106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona].
    Rozman C; Carreras E; Sierra J; Rovira M; Urbano-Ispizua A; Marín P; Bladé J; Cervantes F; López-Guillermo A; Nomdedeu B; Rozman M; Aguilar JL; Vives-Corrons JL; Mazzara R; Ordinas A; Ribera JM; Feliu E; Castillo R; Grañena A; Montserrat E
    Med Clin (Barc); 1997 May; 108(18):681-6. PubMed ID: 9324582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neurologic complications on outcome after heart transplant.
    van de Beek D; Kremers W; Daly RC; Edwards BS; Clavell AL; McGregor CG; Wijdicks EF
    Arch Neurol; 2008 Feb; 65(2):226-31. PubMed ID: 18268192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.
    Siegal D; Keller A; Xu W; Bhuta S; Kim DH; Kuruvilla J; Lipton JH; Messner H; Gupta V
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1369-79. PubMed ID: 17950923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation.
    Weber C; Schaper J; Tibussek D; Adams O; Mackenzie CR; Dilloo D; Meisel R; Göbel U; Laws HJ
    Bone Marrow Transplant; 2008 Feb; 41(3):253-9. PubMed ID: 17982498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant.
    Wendland MM; Smith DC; Boucher KM; Asch JD; Pulsipher MA; Thomson JW; Shrieve DC; Gaffney DK
    Am J Clin Oncol; 2007 Apr; 30(2):156-62. PubMed ID: 17414465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
    Kersting S; Hené RJ; Koomans HA; Verdonck LF
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic complications in children after hemaopoietic stem cell transplantation: a single-center experience.
    Zaucha-Prazmo A; Jasiński M; Drabko K; Choma M; Wójcik B; Kowalczyk JR
    Transplant Proc; 2007 Nov; 39(9):2905-7. PubMed ID: 18022013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic complications of hematopoietic cell transplantation.
    Saiz A; Graus F
    Semin Neurol; 2010 Jul; 30(3):287-95. PubMed ID: 20577935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
    Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.